Zimmer Biomet Holdings, Inc. designs, develops, manufactures, and markets musculoskeletal healthcare products and devices. The company was first known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. This organisation was founded in 1927 as the Zimmer Manufacturing Company. With its headquarters in Warsaw, Indiana, the company operates internationally in North America, South America, the Middle East, Africa, and the Asia Pacific.
The company’s variety of offerings includes reconstruction products such as joint replacements and surgical education and training products. Zimmer Biomet further provides products for sports medicine, biologics, the foot and ankle, extremities, and trauma purposes. Spinal products include medical devices and surgical instruments. Additionally, the company focuses on skull and facial reconstructive therapies and products, as well as fixation and stabilisation measures for bones located in the thoracic cavity after open-heart surgery, trauma, or for chest deformities. Zimmer Biomet also offers dental products such as reconstructive implants, prosthetics, and regenerative products.
Zimmer Biomet's healthcare solutions are directed at patients with disorders or injuries of the skeletal system and joint or supporting soft tissue problems. The company’s customer base includes orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, and other healthcare specialists. Zimmer Biomet trades on the NYSE under the ZBH ticker.
Add Zimmer Biomet to your eToro watchlist to receive news and updates on the ZBH share price.